Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …

Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …

Background Sepsis is a global health challenge associated with significant morbidity and
mortality. Detrimental sepsis effects are attributed to excessive inflammation or a “cytokine …

Coronavirus disease (COVID-19) has spread worldwide and its effects have been more
devastating than any other infectious disease. Importantly, patients with severe COVID-19 …

Nucleic acid aptamers capable of affine and specific binding to their molecular targets have
now established themselves as a very promising alternative to monoclonal antibodies for …

Sepsis is a systemic inflammatory response syndrome caused by infection. Septic patients
often show an acute liver dysfunction during the onset of sepsis in ICU. We found the levels …

Simvastatin had minimum inhibitory concentrations of 32 to 128 µg/mL against Klebsiella
pneumoniae isolates and hindered the biofilm-formation ability of 58.54% of the isolates. It …

Punicalagin is recorded to be a potent anti‐inflammatory drug, while its effect on
inflammation existing in ventilator‐induced lung injury (VILI) requires further verification …

Background Sepsis is a life‐threatening condition caused by a dysregulated host response
to infections and is a leading cause of death in hospitalized patients. The present study …

脓毒症(sepsis) 是感染引起宿主反应失调导致的危及生命的器官功能障碍,
是临床危重症患者死亡的主要原因之一. 最新研究表示脓毒症发病率每年以1.5%~ 9.0 …